2-Deoxystreptamine (2-DOS) aminoglycosides exert their antibiotic actions by binding to the A site of the 16S rRNA and interfering with bacterial protein synthesis. However, the molecular forces that govern the antitranslational activities of aminoglycosides are poorly understood. Here, we describe studies aimed at elucidating these molecular forces. In this connection, we compare the bactericidal, antitranslational, and rRNA binding properties of the 4,5-disubstituted 2-DOS aminoglycoside neomycin (Neo) and a conformationally restricted analog of Neo (CR-Neo) in which the 2-nitrogen atom is covalently conjugated to the 5؆-carbon atom. The bactericidal potency of Neo exceeds that of CR-Neo, with this enhanced antibacterial activity reflecting a correspondingly enhanced antitranslational potency. Time-resolved fluorescence anisotropy studies suggest that the enhanced antitranslational potency of Neo relative to that of CR-Neo is due to a greater extent of drug-induced reduction in the mobilities of the nucleotides at positions 1492 and 1493 of the rRNA A site. Buffer-and salt-dependent binding studies, coupled with high-resolution structural information, point to electrostatic contacts between the 2-amino functionality of Neo and the host rRNA as being an important modulator of 1492 and 1493 base mobilities and therefore antitranslational activities.The increasing prevalence of multidrug-resistant bacterial infections has made the development of new antibiotics an important focus of current pharmacological research. A thorough understanding of the molecular mechanisms that underlie antibiotic action is an essential component of drug development. The 2-deoxystreptamine (2-DOS) aminoglycosides are potent bactericidal agents that target the 16S rRNA A site in the 30S ribosomal subunit, thereby interfering with bacterial protein synthesis (11,12,14,31,45).Recent structural (11, 16-18, 33, 39, 41-43, 47) and biochemical (23, 46) studies have resulted in the proposal of a model for how aminoglycosides exert their deleterious effects on bacterial translation. This model is based on the premise that two conserved adenine residues at positions 1492 and 1493 of the rRNA A site play critical roles in the translation process. According to the model, A1492 and A1493 are in conformational equilibria between intrahelical and extrahelical states. When in their extrahelical states, A1492 and A1493 interact with the codon-anticodon minihelix. This interaction is favored in the presence of a cognate tRNA anticodon and disfavored in the presence of a noncognate tRNA anticodon. The binding of a 2-DOS aminoglycoside shifts the conformational equilibria of A1492 and A1493 toward the extrahelical state, thereby resulting in an enhanced interaction with the codon-anticodon minihelix, even when the tRNA anticodon is noncognate. The net results of this drug-induced effect are mistranslation, premature termination of translation, and inhibition of translation initiation (12). Consistent with this model for the antitranslational impact of am...